BIOMONITOR IV with SmartECG Received FDA Clearance
Image
Announcing</br><b>FDA Approval</b></br>for Prospera<sup>TM</sup> Spinal</br>Cord Stimulation System
none
top_right
Off
AnnouncingFDA Approvalfor ProsperaTM SpinalCord Stimulation System
Image
Just Published
greyblue
DX Technology allows for reliable, guideline-recommended remote monitoring of subclinical AF
top_right
Off
Just Published
Image
BIOTRONIK collaboration with IMDS.
greyblue
Conquering the Complex. Together.
bottom_right
On
greyblue
s
BIOTRONIK collaboration with IMDS.
BIOTRONIK Announces Collaboration with AliveCor
Pulsar-18 T3 Receives FDA Approval
Renamic Neo with LiveSupport Software
Image
Orsiro® Mission DES
pink
<p>FDA Approved<p>
<p>Better Deliverability</p>
<p>Outstanding Outcomes</p>
<p>Better Deliverability</p>
<p>Outstanding Outcomes</p>
bottom_right
On
pink
s
Excellence For Life.
Prof. Max Schaldach founded BIOTRONIK 60 years ago with one focus, changing lives. Our unique revolutionary innovations and technology span cardiac rhythm management, vascular intervention and electrophysiology. BIOTRONIK has been developing trusted and innovative cardiovascular and endovascular solutions. Our innovations enable care that saves and improves the lives of patients diagnosed with heart and blood vessel diseases. With global headquarters in Berlin, Germany and U.S. operations in New York City and Lake Oswego, Oregon, we’re proud to focus on what really matters—our partnerships with healthcare professionals to positively impact patient care. We do this by investing in research and development while never losing sight of the importance of quality and reliability.
ORSIRO® MISSION DRUG-ELUTING STENT SYSTEM
Better Deliverability. Outstanding Patient Outcomes.
BIOTRONIK is a privately owned, global medical device company with products and services that save and improve the lives of patients suffering from cardiovascular and endovascular diseases. Patient well being is our top priority and has been for more than 50 years.